다한증 치료 시장 규모, 점유율 및 성장 분석 : 치료법별, 투여 경로별, 최종사용자별, 유통 채널별, 지역별 - 업계 예측(2026-2033년)

Global Bromhidrosis Disease Treatment Market size was valued at USD 284.5 Million in 2024 and is poised to grow from USD 296.16 Million in 2025 to USD 408.4 Million by 2033, growing at a CAGR of 4.1% during the forecast period (2026-2033).

The bromhidrosis Disease Treatment market is experiencing significant growth driven by increased patient awareness and a broadening array of clinical options that elevate this previously overlooked condition into a prominent therapeutic focus. Characterized by unpleasant body odor due to sweat from apocrine or eccrine glands, bromhidrosis impacts individuals' quality of life and confidence, spurring demand for treatments ranging from topical solutions to surgical interventions. The market is transitioning from traditional deodorants to advanced therapies, including botulinum toxin injections, laser ablation, and targeted liposuction. The preference for minimally invasive options is fostering investment and interest from providers and payers alike, as clinics report elevated patient satisfaction. Furthermore, AI is enhancing diagnosis and treatment personalization through advanced imaging, microbiome profiling, and predictive models, promoting more effective and customized care pathways.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Bromhidrosis Disease Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Bromhidrosis Disease Treatment Market Segments Analysis

Global bromhidrosis disease treatment market is segmented by treatment type, mode of administration, end-user, distribution channel and region. Based on treatment type, the market is segmented into Topical Antiperspirants and Formulations, Botulinum Toxin Injections, Energy-Based and Electrical Devices, Surgical Interventions and Others. Based on mode of administration, the market is segmented into Topical, Injectable and Others. Based on end-user, the market is segmented into Hospitals and Dermatology Clinics, Medical Spas and Aesthetic Centers, Homecare Settings and Others. Based on distribution channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies, Online Healthcare Platforms and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Bromhidrosis Disease Treatment Market

The rising public awareness surrounding bromhidrosis symptoms and treatment options is driving more individuals to pursue medical consultations, subsequently boosting the demand for therapeutic solutions and specialist care. As knowledge about the condition improves, the stigma associated with it diminishes, leading patients to be more open to exploring various clinical and aesthetic treatments. This shift encourages healthcare providers to diversify their service offerings and invest in targeted therapies. Additionally, enhanced understanding among primary care and dermatology professionals promotes early identification and referral to appropriate treatment pathways, thereby supporting the overall growth of the market and fostering the development of customized treatment approaches.

Restraints in the Global Bromhidrosis Disease Treatment Market

The Global Bromhidrosis Disease Treatment market faces significant constraints due to inconsistent coverage policies from insurers and public payers, which limit patient access to various treatment options. This leads to financial barriers that discourage individuals from pursuing regular clinical management and elective procedures. When out-of-pocket expenses are steep, patients often postpone or skip necessary therapies, resulting in diminished demand and hindering market growth. Additionally, vague eligibility criteria and fluctuating reimbursement approvals place added administrative pressures on healthcare providers, dissuading them from adopting clinical practices and investing in specialized services, thus impeding commercialization efforts and restricting the variety of treatment alternatives available.

Market Trends of the Global Bromhidrosis Disease Treatment Market

The Global Bromhidrosis Disease Treatment market is increasingly embracing personalized therapeutic approaches that cater to the unique needs of each patient. By focusing on individualized treatment regimens, healthcare providers are taking into account symptom severity, skin characteristics, and patient preferences, leading to more effective and tolerable solutions. Advances in diagnostic methodologies and multidisciplinary care facilitate precise patient stratification, allowing for optimized treatment selection. This trend emphasizes long-term patient adherence and improved quality of life by integrating diverse treatment modalities, including topical, systemic, and procedural options. Collaborative efforts across dermatology, surgery, and primary care are essential in implementing these tailored management strategies.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Bromhidrosis Disease Treatment Market Size by Treatment Type & CAGR (2026-2033)

• Market Overview
• Topical Antiperspirants and Formulations
  • Creams and Gels
  • Roll-ons and Sprays
• Botulinum Toxin Injections
• Energy-Based and Electrical Devices
• Surgical Interventions
• Others

Global Bromhidrosis Disease Treatment Market Size by Mode of Administration & CAGR (2026-2033)

• Market Overview
• Topical
• Injectable
• Others

Global Bromhidrosis Disease Treatment Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Hospitals and Dermatology Clinics
• Medical Spas and Aesthetic Centers
• Homecare Settings
• Others

Global Bromhidrosis Disease Treatment Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Hospital Pharmacies
• Retail Pharmacies
• Online Healthcare Platforms
• Others

Global Bromhidrosis Disease Treatment Market Size & CAGR (2026-2033)

• North America (Treatment Type, Mode of Administration, End-User, Distribution Channel)
  • US
  • Canada
• Europe (Treatment Type, Mode of Administration, End-User, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Treatment Type, Mode of Administration, End-User, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Treatment Type, Mode of Administration, End-User, Distribution Channel)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Treatment Type, Mode of Administration, End-User, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Allergan Aesthetics (AbbVie)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sientra (miraDry)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Journey Medical (Qbrexza)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Galderma
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merz Therapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly (Dermira)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Brickell Biotech
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TheraVida
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline (GSK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Revance Therapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alma Lasers
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cynosure
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lumenis
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cutera
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Candela
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roivant Sciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kaken Pharmaceutical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations